...
首页> 外文期刊>Journal of computer assisted tomography >Evaluation of the effectiveness of oral Beta-blockade in patients for coronary computed tomographic angiography.
【24h】

Evaluation of the effectiveness of oral Beta-blockade in patients for coronary computed tomographic angiography.

机译:评估口服β-受体阻滞剂在冠状动脉计算机断层血管造影术中的有效性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine the effectiveness of oral medications in lowering the resting heart rate (HR) for coronary computed tomographic angiography (CTA). BACKGROUND: The protocol of premedication for cardiac CTA is variable in terms of type, dose, route, and timing of administration. METHODS: Nursing records were retrospectively reviewed in 238 consecutive patients having coronary CTA and 217 patients evaluated for type and amount of oral medication administered. The HR on arrival to computed tomography (CT) and 30 and 60 minutes after medication was noted. RESULTS: One hundred twenty-three patients (56.6%) had a mean HR of 78.3 +/- 9.4 beats per minute (bpm) on arrival and were given medication. One hundred fourteen patients (92.6%) were given 50 mg of oral metoprolol, with the remaining receiving 25 to 100 mg and 1 patient receiving 30 mg of oral diltiazem. Sixty-eight patients (55.2%) were monitored for less than 1 hour and had a mean HR of 73.1 +/- 5.1 bpm on arrival, a 9.8 +/- 4.7-bpm decrease inHR at 30 minutes, and an HR of 56.5 +/- 7.2 bpm during CT. Thirty-nine patients (31.7%) had a mean HR of 81.3 +/- 7.2 bpm on arrival, a 9.8 +/- 7.4-bpm decrease in HR at 30 minutes, a 16.9 +/- 6.3-bpm decrease in HR at 60 minutes, and an HR of 59.8 +/- 4.8 bpm during CT. Sixteen patients were monitored for more than 1 hour, followed by intravenous metoprolol. These patients had a baseline HR of 93.5 +/- 8.9 bpm, a 13.1 +/- 6.4-bpm decrease in HR at 30 minutes, a 15.9 +/- 6.8-bpm decrease in HR at 60 minutes, and an HR of 68.1 +/- 7.9 bpm during CT. There were no complications due to metoprolol. CONCLUSION: Oral metoprolol given 1 hour before cardiac CT effectively and safely lowers the resting HR in most patients.
机译:目的:确定口服药物在降低冠状动脉计算机断层血管造影术(CTA)的静息心率(HR)方面的有效性。背景:心脏CTA的处方治疗方案在类型,剂量,途径和给药时间方面是可变的。方法:回顾性回顾了238例冠状动脉CTA患者和217例口服药物的类型和使用量的患者的护理记录。注意到在到达计算机断层扫描(CT)以及服药后30和60分钟时的HR。结果:123例患者(56.6%)在到达时的平均HR为每分钟78.3 +/- 9.4次心跳(bpm),并接受药物治疗。 114名患者(92.6%)被给予50 mg口服美托洛尔,其余患者接受25至100 mg,1名患者接受口服地尔硫卓30 mg。监测了68名患者(55.2%),时间少于1小时,到达时的平均HR为73.1 +/- 5.1 bpm,30分钟时的HR下降9.8 +/- 4.7-bpm,HR为56.5 + /-CT期间为7.2 bpm。 39名患者(31.7%)到达时的平均HR为81.3 +/- 7.2 bpm,在30分钟时HR下降9.8 +/- 7.4-bpm,在60时HR下降16.9 +/- 6.3-bpm分钟,CT期间的HR为59.8 +/- 4.8 bpm。监测16例患者1小时以上,然后静脉注射美托洛尔。这些患者的基线HR为93.5 +/- 8.9 bpm,30分钟时HR降低13.1 +/- 6.4-bpm,60分钟时HR降低15.9 +/- 6.8-bpm,HR为68.1 + /-CT期间为7.9 bpm。没有因美托洛尔引起的并发症。结论:心脏CT前1小时口服美托洛尔可有效安全地降低大多数患者的静息心率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号